These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3283 related articles for article (PubMed ID: 26030634)

  • 1. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRISMA harms checklist: improving harms reporting in systematic reviews.
    Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
    BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
    Moher D; Shamseer L; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
    Syst Rev; 2015 Jan; 4(1):1. PubMed ID: 25554246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
    Tricco AC; Lillie E; Zarin W; O'Brien KK; Colquhoun H; Levac D; Moher D; Peters MDJ; Horsley T; Weeks L; Hempel S; Akl EA; Chang C; McGowan J; Stewart L; Hartling L; Aldcroft A; Wilson MG; Garritty C; Lewin S; Godfrey CM; Macdonald MT; Langlois EV; Soares-Weiser K; Moriarty J; Clifford T; Tunçalp Ö; Straus SE
    Ann Intern Med; 2018 Oct; 169(7):467-473. PubMed ID: 30178033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic reviews in orthodontics: Impact of the PRISMA for Abstracts checklist on completeness of reporting.
    Vásquez-Cárdenas J; Zapata-Noreña Ó; Carvajal-Flórez Á; Barbosa-Liz DM; Giannakopoulos NN; Faggion CM
    Am J Orthod Dentofacial Orthop; 2019 Oct; 156(4):442-452.e12. PubMed ID: 31582116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
    Sun X; Zhou X; Yu Y; Liu H
    BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    Int J Equity Health; 2015 Oct; 14():92. PubMed ID: 26450828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration.
    Zhang X; Tan R; Lam WC; Cheng CW; Yao L; Wang XQ; Li SY; Aixinjueluo QY; Yang KH; Shang HC; Wu TX; Lyu AP; Bian ZX
    Syst Rev; 2020 Oct; 9(1):247. PubMed ID: 33100229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.
    Rethlefsen ML; Kirtley S; Waffenschmidt S; Ayala AP; Moher D; Page MJ; Koffel JB;
    Syst Rev; 2021 Jan; 10(1):39. PubMed ID: 33499930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 165.